drugset / Trial / NCT03324607

Effects of Bevespi on Ventilation and Gas Exchange Abnormalities in COPD Assessed by 129Xe MRI

NCT03324607 ↗

Phase 2/3 Completed 20 enrolled Bastiaan Driehuys
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine whether the new inhaler, Bevespi improves lung function. Magnetic resonance imaging (MRI) using inhaled hyperpolarized 129Xe gas, that can provide useful images of the functioning of the lung will be used as a new measure to determine change in function. The investigator anticipate these images will provide more specific information about lung disease than standard lung function tests in response to treatment.

Timeline

Start
2018-04-20
Primary completion
2019-11-12
Completion
2019-11-12

Outcome

Met primary endpoint

registry analysis (other test); Treatment; p = 0.006; Paired t-test NCT03324607 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycopyrrolate/Formoterol Unknown — Inhaled